A Nevada jury is ordering pharmaceutical companies to pay $162.5 million in punitive damages in a lawsuit stemming from a Las Vegas hepatitis C outbreak in 2008.
The damages awarded Monday in Clark County District Court are on top of the $20.1 million in compensatory damages awarded to five plaintiffs Thursday after a jury found Teva Parenteral Medicines Inc., Baxter Healthcare Corp. and McKesson Corp. liable after a seven-week trial.
Plaintiffs’ lawyers had been seeking $600 million in punitive damages.
At least one of the drug companies is planning an immediate appeal.
Plaintiffs accused the drug companies of distributing dangerously large vials of the powerful anesthetic propofol to clinics where doctors and anesthesiologists are suspected of reusing vials – despite warnings that the practice could spread blood-borne diseases.
Was this article valuable?
Here are more articles you may enjoy.
The Field Inspection Gap: A Growing Structural Risk in Claims Handling 
Car Owners Shocked by $200 Gas Bills Finally Embrace Used EVs 
The Future of Appraisal and the Rising Standard of Competency 
OpenAI CEO to Share Oversight Ideas in Wake of Trump AI Order 
Want to stay up to date?
Get the latest insurance news
sent straight to your inbox.